Search
for

    Sort by

    Research 781–810 of 877

    1. Frontal fibrosing alopecia in men: A multicenter study of 39 patients Journal of The American Academy of Dermatology · 2021 · 5 citations
    2. The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata Dermatology and Therapy · 2022 · 4 citations
    3. LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1) Journal of Investigative Dermatology · 2021 · 3 citations
    4. Alopecia Areata–Specific Patient-Reported Outcome Measures JAMA Dermatology · 2025 · 2 citations
    5. Epidemiology of alopecia areata in Hispanic/Latinx patients Journal of the American Academy of Dermatology · 2022 · 2 citations
    6. COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy JAAD case reports · 2022 · 2 citations
    7. Association of frontal fibrosing alopecia and contact allergens in everyday skincare products in Hispanic females: a case-control study Anais Brasileiros de Dermatologia · 2021 · 2 citations
    8. Alopecia areata-like hair loss after a tick bite JAAD Case Reports · 2024 · 1 citations
    9. Eyebrow Transplantation: A Simplified Technique The American Journal of Cosmetic Surgery · 1999 · 1 citations
    10. Long-term hair loss associated with brentuximab vedotin–containing chemotherapy and its psychosocial impact: A retrospective observational study conducted at the Royal Marsden Hospital. Journal of Clinical Oncology · 2026
    11. Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report. PubMed · 2026
    12. Vogt-Koyanagi-Harada Disease with Oral Manifestations: A Rare Case Report Contemporary Clinical Dentistry · 2026
    13. Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps. Open Science Framework · 2026
    14. Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series International Journal of Women’s Dermatology · 2025
    15. Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise Australasian Journal of Dermatology · 2025
    16. Correction to ‘Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study’ Journal of the European Academy of Dermatology and Venereology · 2025
    17. Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil. PubMed · 2025
    18. Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata Cureus · 2025
    19. Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study. PubMed · 2025
    20. Alopecia areata - need for a revision in morphological classification and scoring Medical Research Archives · 2025
    21. Frontal Fibrosing Alopecia: An Observational Single-Center Study of 306 Cases Life · 2023
    22. Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris IntechOpen eBooks · 2022
    23. A case study of using cross-linked hyaluronic acid for upper eyelid rejuvenation International Journal of Health Sciences (IJHS) (En línea) · 2022
    24. Hair Transplantation 2021
    25. Hair Transplantation 2021
    26. Frontal fibrosing alopecia: follow-up of a brazilian group 2019
    27. The Role of Hair Transplantation for Managing Facial Trauma Facial plastic surgery · 2017
    28. Application and Approach to Hair Transplantation in Females The American Journal of Cosmetic Surgery · 1997
    29. Frontal fibrosing alopecia in males: A systematic review JAAD reviews. · 2025 · 2 citations
    30. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results Journal of the American Academy of Dermatology · 2021 · 138 citations